Senescence and tumor suppression

Area of Science:

• Oncology
• Cell Biology
• Immunology

Background:

• Cellular senescence is a key tumor suppression mechanism.
• Senescent cells permanently exit the cell cycle but can harm tissues via the senescence-associated secretory phenotype (SASP).

Purpose of the Study:

• To review the dual role of cellular senescence in tumor suppression and promotion.
• To highlight the senescence-associated secretory phenotype (SASP) as a critical factor in this dichotomy.

Main Methods:

• Literature review of studies on cellular senescence and the SASP.
• Analysis of the impact of senescent cells and SASP on the tumor microenvironment.
• Examination of clinical implications of senescence in cancer therapy.

Main Results:

• Senescence acts as a tumor suppressor by halting proliferation of pre-cancerous cells.
• The SASP contributes to a pro-inflammatory and immunosuppressive microenvironment, potentially promoting tumorigenesis.
• Senescence is a common response to anti-cancer therapies.

Conclusions:

• Senescence has both tumor-suppressive and tumor-promoting effects, mediated by the SASP.
• Persistent senescent cells can create a tumor-promoting microenvironment.
• Therapeutic strategies balancing senescence's growth-inhibitory and detrimental effects hold clinical promise.